Table 6: Relative excess risks of death, with 95% confidence intervals according to age, sex, smoking habit, lung disease, performance status, morphology, stage, surgery, radiotherapy, chemotherapy, targeted treatment and delays in the treatment for lung cancer patients diagnosed in 2011–2012.

 

RER

(95% CI)

p

Age

 

 

 

45-54

1(ref)

 

-

15-44

1.17

(0.61-2.04)

0.620

55-64

1.03

(0.74-1.40)

0.855

65-74

1.27

(0.96-1.74)

0.116

≥75

2.05

(1.49-2.64)

0.001

Sex

 

 

 

Women

1(ref)

 

-

Men

1.78

(1.19-1.90)

0.06

Smoker

 

 

 

No

1(ref)

 

-

Yes

1.88

(1.16-1.97)

0.001

Lungdisease

 

 

 

No

1(ref)

 

-

Yes

1.33

(1.06-1.50)

0.001

Performance status

 

 

 

ECOG<2

1(ref)

 

-

ECOG ≥ 2

2.19

(1.61-2.99)

0.001

Histology

 

 

 

NSmCC

1(ref)

 

-

SmCC

1.44

(1.04-1.65)

0.002

Non-microscopic verification

3.83

(2.62-3.97)

0.001

Stage

 

 

 

I

1(ref)

 

-

II

2.51

(1.18-5.34)

0.01

III

4.23

(2.43-7.37)

0.001

IV

9.70

(5.10-14.86)

0.001

Surgery

 

 

 

Done

1(ref)

 

-

Not done

8.68

(4.44-9.65)

0.001

Radiotherapy

 

 

 

Done

1(ref)

 

-

Not done

1.55

(1.26-1.83)

0.001

Chemotherapy

 

 

 

Done

1(ref)

 

-

Not done

1.59

(1.34-1.88)

0.001

Targeted treatment

 

 

 

Done

1(ref)

 

-

Not done

2.21

(1.19-2.70)

0.001

Delays

 

 

 

No

1 (ref)

 

 

Yes

1.12

(0.86-1.44)

0.38

RER Relative excess risks, CI confidence intervals, ref reference, NSmCC non-small cell carcinoma, SmCC small cell carcinoma